Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Markers of bone status in diabetes mellitus and effect of alendronate on glycemic markers
2024-514148-99-00Phase 4Completed
- Sponsor
- Aalborg University Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alendronate in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), osteopenia and 1 more (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: HbA1c and BMD. Started Jun 2024; status: completed.
02
Drugs
alendronate
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)osteopeniaosteoporosis
Beyond the preview
Go deeper on 2024-514148-99-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514148-99-00.